Goldberg Itzhak's Form 4 filing
Elicio Therapeutics, Inc. (ELTX) · filed Dec 3, 2021
- Accession no.
- 0001601485-21-000079
- Filed
- Dec 3, 2021
- Trade date
- Dec 1-3, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $410.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldberg ItzhakCIK 0001607858 | Director, Officer (See Remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 1, 2021 | Common Stock | SSaleDisposed | −38,867 | $3.54F2 | −$137,589.18 | 1,831,201 | Direct | |
| Dec 2, 2021 | Common Stock | SSaleDisposed | −38,800 | $3.51F3 | −$136,188 | 1,792,401 | Direct | |
| Dec 3, 2021 | Common Stock | SSaleDisposed | −40,215 | $3.39F4 | −$136,328.85 | 1,752,186 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.31 to $3.79 inclusive.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.36 to $3.64 inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.29 to $3.50 inclusive.
Referenced by the price of 1 transaction in Table I.
Remarks
Executive Chairman and Chief Scientific Officer